| __timestamp | Merck & Co., Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 11606000000 | 5078000000 |
| Thursday, January 1, 2015 | 10313000000 | 4717000000 |
| Friday, January 1, 2016 | 9762000000 | 5096000000 |
| Sunday, January 1, 2017 | 9830000000 | 4986000000 |
| Monday, January 1, 2018 | 10102000000 | 4214000000 |
| Tuesday, January 1, 2019 | 10615000000 | 3806000000 |
| Wednesday, January 1, 2020 | 8955000000 | 3671000000 |
| Friday, January 1, 2021 | 9634000000 | 3528000000 |
| Saturday, January 1, 2022 | 10042000000 | 3445000000 |
| Sunday, January 1, 2023 | 10504000000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Merck & Co., Inc. and Teva Pharmaceutical Industries Limited have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Merck's SG&A expenses have fluctuated, peaking in 2014 and 2019, with a notable dip in 2020. This reflects a strategic shift, possibly aligning with broader market dynamics and internal restructuring. In contrast, Teva's SG&A expenses have consistently declined, dropping by approximately 31% from 2014 to 2023. This reduction could indicate a focus on cost-cutting measures or a strategic pivot towards more efficient operations. As these giants navigate the complexities of the global market, their financial strategies offer valuable insights into the industry's future.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
Comparing SG&A Expenses: Merck & Co., Inc. vs Takeda Pharmaceutical Company Limited Trends and Insights
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Verona Pharma plc
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and CymaBay Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Xencor, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Sanofi or Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited and Viatris Inc.: SG&A Spending Patterns Compared
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation